• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对女性生殖健康的影响:英国生育协会政策与实践指南

Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines.

作者信息

Balen Adam H, Anderson Richard A

机构信息

Reproductive Medicine & Surgery, Leeds Teaching Hospitals, Leeds, UK.

出版信息

Hum Fertil (Camb). 2007 Dec;10(4):195-206. doi: 10.1080/14647270701731290.

DOI:10.1080/14647270701731290
PMID:18049955
Abstract

Obesity has a significant adverse impact on reproductive outcome. It influences not only the chance of conception but also the response to fertility treatment, and increases the risk of miscarriage, congenital anomalies and pregnancy complications in addition to potential adverse effects on long term health of both mother and infant. Women should aim for a normal BMI before starting any form of fertility treatment. Treatment should be deferred until the BMI is less than 35 kg/m2, although in those with more time (e.g., less than 37 years; normal serum FSH concentration) a weight reduction to a BMI of less than 30 kg/m2 is preferable. Clinicians should consider deferring treatment to women outside these guidelines. Women should be provided with assistance to lose weight, including psychological support, dietary advice, exercise classes and where appropriate, weight reducing agents or bariatric surgery. Even a moderate weight loss of 5-10% of body weight can be sufficient to restore fertility and improve metabolic markers.

摘要

肥胖对生殖结局有显著的不利影响。它不仅影响受孕几率,还影响对生育治疗的反应,并增加流产、先天性异常和妊娠并发症的风险,此外还可能对母婴的长期健康产生不利影响。女性在开始任何形式的生育治疗前应将体重指数(BMI)控制在正常范围。治疗应推迟到BMI低于35kg/m²,不过对于有更多时间的女性(如年龄小于37岁;血清促卵泡生成素浓度正常),将体重减至BMI低于30kg/m²更佳。临床医生应考虑对超出这些指导原则的女性推迟治疗。应向女性提供减肥帮助,包括心理支持、饮食建议、健身课程,以及在适当情况下使用减肥药物或进行减肥手术。即使体重适度减轻5%-10%也足以恢复生育能力并改善代谢指标。

相似文献

1
Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines.肥胖对女性生殖健康的影响:英国生育协会政策与实践指南
Hum Fertil (Camb). 2007 Dec;10(4):195-206. doi: 10.1080/14647270701731290.
2
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.包含饮食成分的体重管理干预措施对孕妇和产后女性体重相关结局的影响:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812.
3
Differences in pre-conception and pregnancy healthy lifestyle advice by maternal BMI: Findings from a cross sectional survey.孕前及孕期健康生活方式建议因孕妇体重指数而异:一项横断面调查的结果
Midwifery. 2016 Nov;42:38-45. doi: 10.1016/j.midw.2016.09.013. Epub 2016 Sep 23.
4
Bariatric surgery in women of reproductive age: special concerns for pregnancy.育龄期女性的减肥手术:对妊娠的特殊关注。
Evid Rep Technol Assess (Full Rep). 2008 Nov(169):1-51.
5
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review.治疗肥胖并优化育龄女性生育能力的医学疗法:一篇叙述性综述
Reprod Biol Endocrinol. 2025 Jan 6;23(1):2. doi: 10.1186/s12958-024-01339-y.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
The combined effect of BMI and age on ART outcomes.体重指数(BMI)和年龄对辅助生殖技术(ART)结局的综合影响。
Hum Reprod. 2023 May 2;38(5):886-894. doi: 10.1093/humrep/dead042.
8
Preconception and Early-Pregnancy Body Mass Index in Women and Men, Time to Pregnancy, and Risk of Miscarriage.女性和男性的孕前和孕早期体重指数、妊娠时间和流产风险。
JAMA Netw Open. 2024 Sep 3;7(9):e2436157. doi: 10.1001/jamanetworkopen.2024.36157.
9
Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.多囊卵巢综合征合并超重或肥胖妇女的体重指数、体重减轻与妊娠机会的关系:英国的一项回顾性队列研究。
Hum Reprod. 2023 Mar 1;38(3):471-481. doi: 10.1093/humrep/deac267.
10
Health consequences for mother and baby of substantial pre-conception weight loss in obese women: study protocol for a randomized controlled trial.肥胖女性孕前大量减重对母婴健康的影响:一项随机对照试验的研究方案
Trials. 2018 Apr 24;19(1):248. doi: 10.1186/s13063-018-2615-6.

引用本文的文献

1
The effects of remimazolam on the incidence of severe hypoxemia during sedated hysteroscopy for assisted reproduction in overweight or obese patients: a randomized controlled clinical trial.瑞马唑仑对超重或肥胖患者辅助生殖镇静宫腔镜检查期间严重低氧血症发生率的影响:一项随机对照临床试验。
Trials. 2025 Aug 26;26(1):309. doi: 10.1186/s13063-025-09054-8.
2
Significance of Mitochondrial Dynamics in Reproductive Physiology: Current and Emerging Horizons in Mitochondrial Therapy for Assisted Reproductive Technologies.线粒体动力学在生殖生理学中的意义:辅助生殖技术线粒体治疗的现状与新进展
Reprod Med Biol. 2025 Aug 17;24(1):e12672. doi: 10.1002/rmb2.12672. eCollection 2025 Jan-Dec.
3
The relevance of female overweight in infertility treatment: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR).
女性超重与不孕治疗的相关性:意大利生育与不育及生殖医学学会(SIFES-MR)的立场声明
J Assist Reprod Genet. 2025 Apr;42(4):1343-1354. doi: 10.1007/s10815-024-03379-0. Epub 2025 Feb 4.
4
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review.治疗肥胖并优化育龄女性生育能力的医学疗法:一篇叙述性综述
Reprod Biol Endocrinol. 2025 Jan 6;23(1):2. doi: 10.1186/s12958-024-01339-y.
5
Different supplements improve insulin resistance, hormonal functions, and oxidative stress on overweight and obese women with polycystic ovary syndrome: a systematic review and meta-analysis.不同补充剂对患有多囊卵巢综合征的超重和肥胖女性的胰岛素抵抗、激素功能及氧化应激的改善作用:一项系统评价与荟萃分析
Front Endocrinol (Lausanne). 2024 Dec 11;15:1464959. doi: 10.3389/fendo.2024.1464959. eCollection 2024.
6
Nutritional and exercise interventions to improve conception in women suffering from obesity and distinct nosological entities.营养和运动干预措施改善肥胖和不同疾病实体女性的受孕率。
Front Endocrinol (Lausanne). 2024 Jun 28;15:1426542. doi: 10.3389/fendo.2024.1426542. eCollection 2024.
7
Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis.比较运动、饮食和/或药物干预对超重或肥胖的育龄期妇女 BMI、排卵和激素谱的疗效:系统评价和网络荟萃分析。
Hum Reprod Update. 2024 Jul 1;30(4):472-487. doi: 10.1093/humupd/dmae008.
8
Effect of weight loss before in vitro fertilization in women with obesity or overweight and infertility: a systematic review and meta-analysis.肥胖或超重且患有不孕症的女性在体外受精前减肥的效果:系统评价和荟萃分析。
Sci Rep. 2024 Mar 14;14(1):6153. doi: 10.1038/s41598-024-56818-4.
9
Women's lived experiences of sex hormones and life-related to bariatric surgery: an interpretative qualitative study.女性经历的性激素与与减重手术相关的生活:一项解释性定性研究。
BMJ Open. 2023 Jun 23;13(6):e072085. doi: 10.1136/bmjopen-2023-072085.
10
Female obesity and infertility: outcomes and regulatory guidance.女性肥胖与不孕:结局与监管指导。
Acta Biomed. 2022 Aug 31;93(4):e2022278. doi: 10.23750/abm.v93i4.13466.